PCP
ARRY

Perimeter Capital Partners’s Array Biopharma Inc ARRY Stock Holding History

Perimeter Capital Partners’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-181,321
Closed -$908K – 201
2013
Q4 		$908K Sell
181,321
-305,157
-63% -$1.66M 0.45% 109
2013
Q3 		$3.03M Sell
486,478
-154,799
-24% -$920K 0.56% 85
2013
Q2 		$2.91M Buy
+641,277
New +$3.45M 0.56% 88

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perimeter Capital Partners's ARRY Position: Q1 2014 in Review

Perimeter Capital Partners sold out of Array Biopharma Inc (ARRY) in Q1 2014, closing a stake of 181,321 shares — an estimated $908K sold.

Perimeter Capital Partners first reported a position in ARRY in Q2 2013 and held it in 3 quarters. The position peaked at $3.03M in Q3 2013. 122 funds tracked by Wall St. Rank hold ARRY as of Q1 2014.

  • Perimeter Capital Partners reported no remaining Array Biopharma Inc position as of Q1 2014 after selling out during the quarter.
  • Perimeter Capital Partners sold 181,321 Array Biopharma Inc shares in Q1 2014, an estimated $908K.
  • Perimeter Capital Partners first reported a position in Array Biopharma Inc in Q2 2013 and held it in 3 quarters.
  • Perimeter Capital Partners's Array Biopharma Inc position peaked at $3.03M in Q3 2013.
  • 122 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2014.

Based on Perimeter Capital Partners's 13F filing for Q1 2014, filed 5 May 2014.